Dynamic Model for Predicting Death Within 12 Months in Patients With Primary or Post–Polycythemia Vera/Essential Thrombocythemia Myelofibrosis

PURPOSE: Current prognostic tools in myelofibrosis (MF) fail to identify patients at the highest risk of death and are limited by their applicability only to the time of diagnosis. We aimed to define an accelerated phase (AP) in MF by characterizing disease features that can identify patients with m...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Clin Oncol
Autors principals: Tam, Constantine S., Kantarjian, Hagop, Cortes, Jorge, Lynn, Alice, Pierce, Sherry, Zhou, Lingsha, Keating, Michael J., Thomas, Deborah A., Verstovsek, Srdan
Format: Artigo
Idioma:Inglês
Publicat: American Society of Clinical Oncology 2009
Matèries:
ORIGINAL REPORTS
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4979081/
https://ncbi.nlm.nih.gov/pubmed/19786661
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.22.8833
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars